Idacta mAb INT-001 represents an interesting clinical approach for treating certain blood-related cancers. The antigen-binding protein is the special process of function, specifically interacting with CD38, the https://monicaunza054601.wikipublicity.com/8552867/idacta_mab_int_001_an_new_antigen_binding_protein_during_progression